Abstract
Acinetobacter baumannii is one of the highly antibiotic-resistant bacteria that cause infections with high rate of death. This bacterium is one the common causes of infection worldwide leading to endemic and epidemic nosocomial infections. Despite many efforts, there is no effective vaccine against A. baumannii. As NlpA is one of the important antigenic factors in biogenesis of outer membrane vesicles, and OMV-based reported vaccines in A. baumannii stimulated the immune responses, this study was aimed to clone and express nlpA gene in eukaryotic HDF cells and evaluate the induced immunization following the administration of resulting construct as DNA vaccine in BALB/c mice. The nlpA gene of A. baumannii was amplified using PCR. The PCR product was then cloned and subcloned into the pTZ57R/T and pEGFP-C2 vectors respectively. The cloning was confirmed by PCR, restriction enzyme digestion and DNA sequencing. The pEGFP-C2-nlpA recombinant plasmid was transferred into the HDF cells using electroporation and the expression of target gene was validated by RT-PCR. The recombinant construct was injected to BALB/c mice through three IM injections and the levels of IgG, IgM, INF-γ, IL-2, IL-4, and IL-12 were determined using ELISA assay. The A. baumannii nlpA gene was amplified during PCR as 867 bp band which was successfully cloned in pEGFP-C2-nlpA vector. Obtained data from RT-PCR and presence of the 867 bp fragment in transformed HDF cells confirmed the nlpA gene expression. Following the injection of pEGFP-C2-nlpA showed the increased level of IgG, IgM, INF-γ, IL-2, IL-4, and IL-12 in serum of immunized mice. Overall, through this study recombinant pEGFP-C2-nlpA was generated and successfully expressed the A. baumannii nlpA gene in eukaryotic cells. Additionally, our in vivo study confirmed that the recombinant construct capable to induce the immune response in immunized mice. These findings suggest the pEGFP-C2-nlpA may be considered as DNA vaccine candidate against A. baumannii.
Similar content being viewed by others
References
Ansari H, Doosti A, Kargar M, Bijanzadeh M, Jafarinya M (2017) Antimicrobial resistant determination and prokaryotic expression of smpA gene of Acinetobacter baumannii Isolated from admitted patients. Jundishapur J Microbiol 10:e59370. https://doi.org/10.5812/jjm.59370
RazaviNikoo H, Ardebili A, Mardaneh J (2017) Systematic review of antimicrobial resistance of clinical Acinetobacter baumannii isolates in Iran: an update. Microb Drug Res 23:744–756. https://doi.org/10.1089/mdr.2016.0118
Amorim AM, Nascimento JD (2017) Acinetobacter: an underrated foodborne pathogen? J Infect Dev Ctries 11:111–114
Ansari H, Kargar M, Bizhanzadeh M, Jafarinya M, Doosti A (2017) Cloning and sequencing of the ompA and smpA virulence genes of Acentobacter baumannii isolated in clinical samples. Armaghane-danesh 21:1207–1217
Odewale G, Adefioye OJ, Ojo J, Adewumi FA, Olowe OA (2016) Multidrug resistance of AcinetobacterBaumanniiin ladoke University Teaching Hospital, Osogbo, Nigeria. Eur J Microbiol Immunol (Bp) 6:238–243
Pourhajibagher M, Hashemi FB, Pourakbari B, Aziemzadeh M, Bahador A (2016) Antimicrobial resistance of Acinetobacter baumannii to imipenem in Iran: a systematic review and meta-analysis. Open Microbiol J 10:32–42
Ni Z, Chen Y, Ong E, He Y (2017) Antibiotic resistance determinant-focused Acinetobacter baumannii vaccine designed using reverse vaccinology. Int J Mol Sci 18:E458. https://doi.org/10.3390/ijms18020458
García Quintanilla M, Pulido MR, Pachón J, McConnell MJ (2014) Immunization with lipopolysaccharide-deficient whole cells provides protective immunity in an experimental mouse model of Acinetobacter baumannii infection. PLoS ONE 9:e114410. https://doi.org/10.1371/journal.pone.0114410
Singh R, Garg N, Shukla G, Capalash N, Sharma P (2016) Immunoprotective efficacy of Acinetobacter baumannii outer membrane protein, FilF, predicted in silico as a potential vaccine candidate. Front Microbiol 7:158. https://doi.org/10.3389/fmicb.2016.00158
Ahmad TA, Tawfik DM, Sheweita SA, Haroun M, El-Sayed LH (2016) Development of immunization trials against Acinetobacter baumannii. Trials Vaccinol 5:53–60
Schwechheimer C, Kuehn MJ (2013) Synthetic effect between envelope stress and lack of outer membrane vesicle production in Escherichia coli. J Bacteriol 195(18):4161–4173
Bodero MD, Pilonieta MC, Munson GP (2007) Repression of the inner membrane lipoprotein NlpA by Rns in enterotoxigenic Escherichia coli. J Bacteriol 189:1627–1632
Schwechheimer C, Kulp A, Kuehn MJ (2014) Modulation of bacterial outer membrane vesicle production by envelope structure and content. BMC Microbiol 14:324. https://doi.org/10.1186/s12866-014-0324-1
Yamaguchi K, Inouye M (1988) Lipoprotein 28, an inner membrane protein of Escherichia coli encoded by nlpA, is not essential for growth. J Bacteriol 170:3747–3749
Doosti A, Doosti E, Rahimi E, Ghasemi-Dehkordi P (2017) Frequency of antimicrobial-resistant genes in Salmonella enteritidis isolated from traditional and industrial iranian white cheeses. Proc Natl A Sci India B 87:73–80
McConnell MJ, Rumbo C, Bou G, Pachón J (2011) Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii. Vaccine 29:5705–5710
Wang Q, Cao W, Yang ZG, Zhao GF (2015) DC targeting DNA vaccines induce protective and therapeutic antitumor immunity in mice. Int J Clin Exp Med 8:17565–17577
Taneja N, Singh G, Singh M, Sharma M (2011) Emergence of tigecycline and colistin resistant Acinetobacter baumanii in patients with complicated urinary tract infections in north India. Indian J Med Res 133:681–684
Moradi J, Hashemi FB, Bahador A (2015) Antibiotic resistance of Acinetobacter baumannii in Iran: a systemic review of the published literature. Osong Public Health Res Perspect 6:79–86
Huang W, Wang S, Yao Y, Xia Y, Yang X et al (2015) OmpW is a potential target for eliciting protective immunity against Acinetobacter baumannii infections. Vaccine 33:4479–4485
Huang W, Yao Y, Wang S, Xia Y, Yang X et al (2016) Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii. Sci Rep 6:20724. https://doi.org/10.1038/srep20724
Lin L, Tan B, Pantapalangkoor P, Ho T, Hujer AM, Taracila MA et al (2013) Acinetobacter baumannii OmpA vaccine dose alters immune polarization and immunodominant epitopes. Vaccine 31:313–318
Huang W, Yufeng Y, Qiong L, Xu Y, Wenjia S, Cunbao Let al (2014) Immunization against multidrug-resistant Acinetobacter baumannii effectively protects mice in both pneumonia and sepsis models. PLoS ONE 9:e100727
Esmaeilkhani H, Rasooli I, Nazarian S, Sefid F (2016) In vivo validation of the immunogenicity of recombinant Baumannii Acinetobactin utilization a protein (rBauA). Microb Pathog 98:77–81
Modarresi F, Azizi O, Shakibaie MR, Motamedifar M, Mansouri S (2016) Cloning and expression of quorum sensing N-acyl-homoserine synthase (LuxI) gene detected in Acinetobacter baumannii. Iran J Microbiol 8:139–143
Alzubaidi AN, Alkozai ZM (2015) Immunogenic properties of outer membrane protein of Acinetobacter baumannii that loaded on chitosan nanoparticles. Am J BioMed 3:59–74
Acknowledgements
The authors wish to thank the staff of Biotechnology Research Center of Shahrekord Branch, Islamic Azad University and Ahvaz Jundishapur University of Medical Sciences for their help.
Author information
Authors and Affiliations
Contributions
RH; literature review, manuscript writing and data collection. AD; literature review and manuscript revision. MK; manuscript revision and MJ; literature review.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Hashemzehi, R., Doosti, A., Kargar, M. et al. Cloning and expression of nlpA gene as DNA vaccine candidate against Acinetobacter baumannii. Mol Biol Rep 45, 395–401 (2018). https://doi.org/10.1007/s11033-018-4167-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-018-4167-y